EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP/ABCG2) inhibitors

Julia de Paula Dutra, Gustavo Scheiffer, Thales Kronenberger, Lucas Julian Cruz Gomes, Isadora Zanzarini, Kelly Karoline Dos Santos, Arun K Tonduru, Antti Poso, Fabiane Gomes de Moraes Rego, Geraldo Picheth, Glaucio Valdameri, Vivian Rotuno Moure

EXCLI Journal · 14.11.2023 · 22 · 1155-1172

DOI: 10.17179/excli2023-6427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EXCLI Journal, online erschienen am 14.11.2023. Verfasst von Julia de Paula Dutra und 11 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Pharmaceutical Sciences, Laboratory of Cancer Drug Resistance, Federal University of Parana, Curitiba, PR, Brazil. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A current clinical challenge in cancer is multidrug resistance (MDR) mediated by ABC transporters. Breast cancer resistance protein (BCRP) or ABCG2 transporter is one of the most important ABC transporters implicated in MDR and the use of inhibitors is a promising approach to overcome the resistance in cancer. This study aimed to characterize the molecular mechanism of ABCG2 inhibitors identified by a repurposing drug strategy using antiviral, anti-inflammatory and antiparasitic agents. Lopinavir and ivermectin can be considered as pan-inhibitors of ABC transporters, since both compounds inhibited ABCG2, P-glycoprotein and MRP1. They inhibited ABCG2 activity showing IC50 values of 25.5 and 23.4 µM, respectively. These drugs were highly cytotoxic and not transported by ABCG2. Additionally, these drugs increased the 5D3 antibody binding and did not affect the mRNA and protein expression levels. Cell-based analysis of the type of inhibition suggested a non-competitive inhibition, which was further corroborated by in silico approaches of molecular docking and molecular dynamics simulations. These results showed an overlap of the lopinavir and ivermectin binding sites on ABCG2, mainly interacting with E446 residue. However, the substrate mitoxantrone occupies a different site, binding to the F436 region, closer to the L554/L555 plug. In conclusion, these results revealed the mechanistic basis of lopinavir and ivermectin interaction with ABCG2.

Schlagwörter

Stichwörter der Autor:innen

ABCG2ABCG2 inhibitorsdrug repositioningivermectinlopinavirmolecular modelling

Autor:innen und Institutionen

  • Graduate Program in Pharmaceutical Sciences, Laboratory of Cancer Drug Resistance, Federal University of Parana, Curitiba, PR, Brazil.
  • School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland.
  • (a) Department of Internal Medicine VIII, University Hospital Tuebingen, Otfried-Müller-Strasse 14, Tuebingen DE 72076, Germany, (b) Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmaceutical Scie…
  • Graduate Program in Pharmaceutical Sciences, Federal University of Parana, Curitiba, PR, Brazil.

Zitieren

APA

Dutra, J. P., Scheiffer, G., Kronenberger, T., Gomes, L. J. C., Zanzarini, I., Dos Santos, K. K., Tonduru, A. K., Poso, A., Rego, F. G. M., Picheth, G., Valdameri, G., & Moure, V. R. (2023). Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP/ABCG2) inhibitors. EXCLI Journal, 22, 1155-1172. https://doi.org/10.17179/excli2023-6427

Vancouver

Dutra JP, Scheiffer G, Kronenberger T, Gomes LJC, Zanzarini I, Dos Santos KK, et al. Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP/ABCG2) inhibitors. EXCLI Journal. 2023;22:1155-1172. doi:10.17179/excli2023-6427

BibTeX
@article{Dutra2023,
  author = {Dutra, Julia de Paula and Scheiffer, Gustavo and Kronenberger, Thales and Gomes, Lucas Julian Cruz and Zanzarini, Isadora and Dos Santos, Kelly Karoline and Tonduru, Arun K and Poso, Antti and Rego, Fabiane Gomes de Moraes and Picheth, Geraldo and Valdameri, Glaucio and Moure, Vivian Rotuno},
  title = {Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP/ABCG2) inhibitors},
  journal = {EXCLI Journal},
  year = {2023},
  volume = {22},
  pages = {1155--1172},
  doi = {10.17179/excli2023-6427}
}
Kostenlos starten →